Is It Doom and Gloom Time for Canadian Cannabis Market? Will the Bubble Burst for Pot Stocks?

The cannabis industry is predicted to be one of the most lucrative businesses worldwide. It is staged to be a $1 trillion industry in the US alone and a $2 trillion business globally. It affects a variety of other industries and it has the stock market watching eagerly for its next move. Leading Canadian venture capitalist, Peter McCullagh, explains that approximately $49 billion have been spent building the industry in Canada and the US and it is ready to explode. It develops faster than the tech industry as it changes every quarter whereas the tech industry changes every nine months.

He goes on to explain that, in the cannabis industry, there are companies that are looking to consolidate, companies that are looking to be bought, and companies that will not last. He even predicts a huge crash in Canadian cannabis stocks within the next 10 years. This will be caused by legalization moving across the US. The business will follow US legalization and move out of Canada. This is typical of many Canadian industries and the cannabis industry is no different. The business will follow where the money is and the sheer size and population of the US guarantees business there.

The president of Canopy Rivers, the venture capital portion of Canopy Growth Corp., believes that the industry will move to synthetic cannabis just as aspirin, originally sourced from the willow tree, is now a pharmaceutical drug. He further explains that there are five stages of the cannabis industry beginning with cultivation first, the development of low-cost technologies second, developing cannabis as a packaged good third, entry into the pharmaceutical industry fourth, and finally the mass market stage which will include the development of orphan drugs and clinical trials. Additionally, as with any industry, there will be litigation and a fight for control.

There are also rumours that production will be moved to Africa and Eastern Europe to lower costs with Germany being one of the main markets. It is likely that these budget markets will not be supported by the Canadian and US industries as well as other countries looking to receive taxation from the cannabis industry. Further, Justin Ort, the CIO of Measure Eight Venture Partners, believes that the competitive CBD market will eventually be dominated by six or seven major brands after consolidation in North America and Europe. As for cannabis stocks, the world watches and waits as the story is set to unfold over the next decade or so.

Arina Paulson

Arina has a Master’s degree in Business and lives in Sydney, Australia and is one of our top contributors as a postgraduate qualified writer. While being a Member Of The Appraisal Institute, she focuses her writing efforts on health, home, business, technology and now cannabis/cbd here.

Share

Recent Posts

  • Gummies

Condor CBD Gummies – Shocking Customer Scam Concerns?

The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…

2 years ago
  • Guides

Best Delta 8 THC Products – And Why You Need To Try Them

Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…

3 years ago
  • Guides

VidaCap: What To Know About the Best Mushroom Supplements Brand

With more people turning towards natural remedies in recent years, mushroom supplements have taken the…

3 years ago
  • Topicals & Salves

Circle Labs CBD: Legit Hemp Pain Relief Balm That Works?

The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…

3 years ago
  • Gummies

Kara’s Orchards CBD Gummies: Safe Full Spectrum Hemp Extract

If anyone is looking for a CBD supplement that is packed with all the necessary…

3 years ago
  • Tinctures & Drops

Sage Elixir CBD: Legit Sage Elixir CBD Oil Tincture or Not?

If anyone has been searching the internet for all the benefits of CBD and where…

3 years ago